Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

New England Journal of Medicine - Tập 372 Số 8 - Trang 724-734 - 2015
Sandra M. Swain1, José Baselga2, Sung‐Bae Kim3, Jungsil Ro4, Angelo Di Leo5, Mario Campone, Eva Ciruelos6, Jean-­Marc Ferrero7, Andreas Schneeweiß8, Sarah Heeson9, Emma Clark9, Graham Ross9, Mark Benyunes10, Javier Cortés11
1Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC
2Memorial Sloan Kettering Cancer Center, Memorial Hospital, New York
3Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
4Center for Breast Cancer, National Cancer Center, Goyang
5N. N. Petrov Research Institute of Oncology, St. Petersburg, Russia
612 de Octubre University Hospital, Medical Oncology Department, Madrid
7Centre Antoine Lacassagne, Nice
8National Center for Tumor Diseases, University Hospital, Heidelberg, Germany
9Roche Products, Welwyn, United Kingdom
10Genentech, South San Francisco, CA
11Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1634/theoncologist.2008-0230

10.1158/0008-5472.CAN-03-3856

10.1158/0008-5472.CAN-08-4597

10.1056/NEJMoa1113216

10.1016/S1470-2045(13)70130-X

10.1634/theoncologist.2012-0448

10.1200/JCO.2006.06.4451

10.1093/jnci/92.3.205

10.1056/NEJM200103153441101

10.1200/JCO.2005.04.173

10.1200/JCO.2010.30.8213

10.1200/JCO.2010.28.6450

10.1093/annonc/mdt543

10.1093/annonc/mdt274

10.1200/JCO.2009.24.2024

10.1200/JCO.2011.37.4207

10.1016/S1470-2045(11)70336-9

10.1158/1078-0432.CCR-14-1268

10.1186/bcr3690

10.1200/JCO.2013.54.5384

10.1200/JCO.2008.19.6618

10.1200/JCO.2011.35.6725

10.1002/cncr.28689

10.1634/theoncologist.2014-0227

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 372 Số 8

724-734

Thông tin tác giả